Cefdinir kills bacteria by breaking down their ability to build and maintain cell walls. It belongs to a class of antibiotics called third-generation cephalosporins, and it’s taken by mouth to treat common infections like sinusitis, ear infections, bronchitis, pneumonia, strep throat, and skin infections. Understanding how it works can help you make sense of why your doctor chose it and what to expect while taking it.
How Cefdinir Destroys Bacteria
Bacteria survive by constantly building and repairing a rigid outer structure called the cell wall. This wall is made of a mesh-like material called peptidoglycan, which acts like scaffolding holding the cell together. Building this scaffolding requires a final critical step: enzymes must cross-link the individual chains of the mesh so it forms a strong, intact barrier.
Cefdinir works by binding to the enzymes responsible for that cross-linking step. These enzymes sit on the inner membrane of the bacterial cell, and once cefdinir latches onto them, they can no longer stitch the wall together. Without proper cross-linking, the cell wall weakens. As the bacterium tries to grow or divide, the defective wall can’t hold, and the cell bursts open from its own internal pressure. This is why cefdinir is considered bactericidal: it doesn’t just slow bacteria down, it kills them outright.
Which Bacteria It Targets
Cefdinir covers a useful range of both gram-positive and gram-negative bacteria, which is why it shows up so often in prescriptions for everyday infections. On the gram-positive side, it’s effective against Strep pneumoniae (a leading cause of sinus and ear infections), Strep pyogenes (the bacterium behind strep throat), and Staph aureus, though only strains that haven’t developed methicillin resistance. On the gram-negative side, it handles Haemophilus influenzae and Moraxella catarrhalis, two bacteria commonly involved in bronchitis, sinusitis, and ear infections.
That said, cefdinir has clear limits. It does not work against MRSA, Pseudomonas, or Enterococcus species. It also fails against strep strains that have become resistant to penicillin. Some bacteria produce specialized enzymes that can chew up the drug’s core structure before it has a chance to work. While cefdinir resists many of the common versions of these enzymes better than older cephalosporins do, certain extended-spectrum varieties can still break it down.
How Your Body Absorbs and Eliminates It
Cefdinir is taken orally, either as a capsule or a liquid suspension. Its bioavailability is relatively low compared to some antibiotics: roughly 21% of a 300 mg capsule dose and about 25% of the liquid form actually reaches your bloodstream. Despite this, enough of the drug gets absorbed to maintain effective concentrations at the site of infection for common conditions.
Blood levels peak about 2 to 4 hours after you take a dose. From there, the drug is cleared mainly through the kidneys, with an average half-life of about 1.7 hours. That relatively short half-life is why cefdinir is typically dosed either once or twice a day depending on the infection, keeping levels high enough between doses to continue killing bacteria.
What It’s Prescribed For
For adults, cefdinir is commonly prescribed at 300 mg twice daily or 600 mg once daily, with treatment courses lasting 5 to 10 days depending on the infection. Community-acquired pneumonia and skin infections typically call for the twice-daily schedule over 10 days. Sinus infections and bronchitis flare-ups can go either way.
In children, dosing is weight-based. The total daily dose for all pediatric infections is 14 mg/kg, split into once- or twice-daily doses, with a ceiling of 600 mg per day. Kids weighing 43 kg (about 95 pounds) or more get the standard adult dose. The liquid suspension makes it practical for young children who can’t swallow capsules. Ear infections, sinus infections, strep throat, and skin infections are the most common reasons children are prescribed cefdinir.
The Iron Interaction and Red Stool
One side effect catches many parents and patients off guard: reddish or rust-colored stool. This happens when cefdinir reacts with iron in the digestive tract. Iron-fortified baby formula, iron supplements, and even iron-rich multivitamins can all trigger it. The drug forms a chemical complex with the iron, and the resulting compound has a distinctive reddish color.
This is completely harmless. The stool tests negative for blood, and the discoloration stops once you finish the antibiotic or separate it from iron-containing products. Still, it understandably alarms people who aren’t expecting it, especially parents checking a baby’s diaper. If you’re taking iron supplements, spacing them a few hours apart from your cefdinir dose can reduce both the discoloration and any potential reduction in how well either product is absorbed.
Cross-Reactivity With Penicillin Allergy
Because cefdinir shares a core structural feature with penicillin (a ring structure called the beta-lactam ring), people with penicillin allergies sometimes wonder whether it’s safe for them. The risk is low. Third-generation cephalosporins like cefdinir have a cross-reactivity rate below 1% in people with confirmed, immune-mediated penicillin allergies. That’s significantly lower than the 1% to 8% range seen with first- and second-generation cephalosporins. For most people with a penicillin allergy history, cefdinir is considered a reasonable option, though the decision depends on the nature and severity of the original allergic reaction.
Why Some Infections Don’t Respond
If you’ve been prescribed cefdinir and your symptoms aren’t improving after a few days, the issue is usually one of two things: the bacteria causing your infection are naturally outside cefdinir’s range, or they’ve developed resistance. Resistance most commonly arises when bacteria produce enzymes that break apart the beta-lactam ring at the heart of the drug’s structure. Without that ring intact, cefdinir can’t bind to its target enzymes, and cell wall synthesis continues uninterrupted.
Some bacteria sidestep the drug through a different route entirely: they alter the shape of the target enzymes so cefdinir can no longer latch on. This is the mechanism behind methicillin-resistant Staph aureus (MRSA), which is why cefdinir is never appropriate for MRSA infections. When an infection doesn’t respond, your doctor may switch to a different class of antibiotic that attacks bacteria through an entirely different mechanism.